Your browser is no longer supported. Please, upgrade your browser.
Settings
IMMU Immunomedics, Inc. daily Stock Chart
IMMU [NASD]
Immunomedics, Inc.
Index- P/E- EPS (ttm)-1.86 Insider Own1.50% Shs Outstand148.51M Perf Week2.31%
Market Cap2.43B Forward P/E- EPS next Y-0.40 Insider Trans110.95% Shs Float142.78M Perf Month-9.61%
Income-233.80M PEG- EPS next Q-0.14 Inst Own78.30% Short Float19.73% Perf Quarter41.36%
Sales3.30M P/S736.70 EPS this Y-135.30% Inst Trans7.55% Short Ratio9.26 Perf Half Y72.86%
Book/sh0.11 P/B148.82 EPS next Y81.00% ROA-178.30% Target Price20.33 Perf Year230.04%
Cash/sh0.94 P/C17.39 EPS next 5Y- ROE391.00% 52W Range4.73 - 18.93 Perf YTD1.30%
Dividend- P/FCF- EPS past 5Y-44.67% ROI-200.90% 52W High-13.52% Beta1.51
Dividend %- Quick Ratio1.30 Sales past 5Y-37.60% Gross Margin77.00% 52W Low246.09% ATR0.94
Employees138 Current Ratio1.30 Sales Q/Q50.00% Oper. Margin- RSI (14)54.34 Volatility4.85% 5.98%
OptionableYes Debt/Eq1.15 EPS Q/Q93.00% Profit Margin- Rel Volume0.37 Prev Close16.38
ShortableYes LT Debt/Eq1.15 EarningsFeb 08 AMC Payout- Avg Volume3.04M Price16.37
Recom1.30 SMA20-0.43% SMA505.18% SMA20045.64% Volume1,134,305 Change-0.06%
May-05-17Upgrade Wells Fargo Market Perform → Outperform
Oct-06-16Resumed Jefferies Buy
Jun-21-16Downgrade Wells Fargo Outperform → Market Perform
May-06-16Upgrade Jefferies Hold → Buy
Dec-04-15Downgrade Wells Fargo Outperform → Market Perform
Jul-29-15Downgrade Jefferies Buy → Hold
Aug-27-14Downgrade R. F. Lafferty Buy → Neutral $4
Jan-08-14Initiated Chardan Capital Markets Buy $9
Oct-02-13Reiterated Oppenheimer Outperform $6 → $8
Sep-10-13Initiated R. F. Lafferty Buy $8
Jun-03-13Initiated WallachBeth Buy $6
Aug-31-11Initiated Summer Street Research Buy $8
Jul-28-11Initiated Summer Street Research Buy $8
Jul-13-11Resumed Brean Murray Buy $8
May-17-11Initiated Oppenheimer Outperform $6
Feb-23-11Initiated Wedbush Outperform $6
Jul-03-07Initiated Brean Murray Buy $8
Feb-20-07Initiated Lazard Capital Buy $6
Feb-15-18 08:00AM  Immunomedics to Participate in RBC Capital Markets 2018 Global Healthcare Conference GlobeNewswire
07:30AM  Fennec Pharma (FENC): The Most Likely Acquisition Target in Healthcare with 200-300% Upside? ACCESSWIRE
Feb-14-18 07:30AM  Blog Exposure - FDA Accepts Amicus Therapeutics NDA for Migalastat for Treatment of Fabry Disease ACCESSWIRE
Feb-13-18 03:49PM  8 Companies That Could Disappear by 2019 InvestorPlace
Feb-09-18 05:01AM  Immunomedics reports 2Q loss Associated Press
Feb-08-18 04:15PM  Immunomedics Announces Second Quarter Fiscal 2018 Results and Provides Corporate Update GlobeNewswire
Feb-06-18 08:00AM  Immunomedics to Report Second Quarter Fiscal 2018 Results and Host Conference Call and Webcast on February 8, 2018 GlobeNewswire
Jan-31-18 08:20AM  New Research: Key Drivers of Growth for Cavco Industries, National Commerce, The Providence Service, Cisco, Immunomedics, and Emergent Biosolutions Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Jan-17-18 07:00AM  Best ETFs for 2018: The SPDR S&P Biotech ETF (XBI) Will Continue to Rock InvestorPlace
Jan-11-18 08:00AM  Immunomedics Announces Agreement with University of Wisconsin Carbone Cancer Center to Expand Sacituzumab Govitecan (IMMU-132) into Prostate Cancer GlobeNewswire
Jan-10-18 08:00AM  Todays Research Reports on Stocks to Watch: Immunomedics, Inc. and Axsome Therapeutics ACCESSWIRE
Jan-08-18 08:30AM  Immunomedics and Royalty Pharma Announce Royalty Funding and Stock Purchase Agreements Totalling $250 Million GlobeNewswire
Jan-04-18 08:45AM  Immunomedics to Present at the 36th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-28-17 11:34AM  Harry Boxer: These two marijuana stocks are climbing higher MarketWatch
Dec-22-17 11:41AM  ETFs with exposure to Immunomedics, Inc. : December 22, 2017 Capital Cube +6.08%
Dec-21-17 12:23PM  BlackBerry Among Four Stocks Breaking Out Forbes
Dec-13-17 07:02AM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Immunomedics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Dec-11-17 01:59PM  ETFs with exposure to Immunomedics, Inc. : December 11, 2017 Capital Cube
Dec-08-17 01:59PM  5 Cheap Biotech Stocks to Snag on the Bounce InvestorPlace
07:45AM  Immunomedics' Data Is Good News for Seattle Genetics, Too Motley Fool
07:16AM  Immunomedics, Inc. breached its 50 day moving average in a Bullish Manner : IMMU-US : December 8, 2017 Capital Cube
Dec-07-17 08:10AM  Todays Research Reports on Stocks to Watch: Immunomedics and Valeant Pharmaceuticals ACCESSWIRE +16.16%
Dec-06-17 03:58PM  Why Immunomedics, Inc. Is Soaring Today Motley Fool +13.00%
12:10PM  Immunomedics Announces Updated Results With Sacituzumab Govitecan (IMMU-132) In Patients With Relapsed Or Refractory Metastatic Triple-Negative Breast Cancer (mTNBC) GlobeNewswire
Nov-30-17 02:00PM  ETFs with exposure to Immunomedics, Inc. : November 30, 2017 Capital Cube
Nov-29-17 08:04AM  Immunomedics, Inc. :IMMU-US: Earnings Analysis: Q1, 2018 By the Numbers : November 29, 2017 Capital Cube
Nov-28-17 08:05AM  Immunomedics, Full Study Data to be Presented December 6, 2017, BLA Application as Early as 1Q18 ACCESSWIRE
Nov-27-17 08:05AM  Analysis: Positioning to Benefit within Aradigm, General Motors, AT&T, Denbury Resources, Novavax, and Immunomedics Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Nov-20-17 07:40AM  Featured Company News - Biohaven Pharma Completed Enrollment in First of Two Pivotal Phase-3 Clinical Trials of Rimegepant for Acute Treatment of Migraine ACCESSWIRE
Nov-16-17 08:43AM  Options Traders Expect Huge Moves in Immunomedics (IMMU) Stock Zacks +8.11%
Nov-15-17 08:38AM  Immunomedics (IMMU) Jumps: Stock Rises 5.4% Zacks +5.31%
Nov-14-17 04:07PM  Edited Transcript of IMMU earnings conference call or presentation 9-Nov-17 10:00pm GMT Thomson Reuters StreetEvents +5.40%
12:44PM  Cowen Bets on Immunomedics Securing Accelerated Approval Even After Decreased Overall Survival Seen in IMMU-132 Abstract SmarterAnalyst
Nov-13-17 04:30PM  Why Sears Holdings, Immunomedics, and J.C. Penney Slumped Today Motley Fool -19.35%
09:30AM  Immunomedics Announces Presentations and Investor Event at the 2017 San Antonio Breast Cancer Symposium GlobeNewswire
07:24AM  Immunomedics, Inc. breached its 50 day moving average in a Bullish Manner : IMMU-US : November 13, 2017 Capital Cube
Nov-10-17 03:02PM  Why Immunomedics, Inc. Jumped Higher Today Motley Fool +18.77%
08:20AM  Todays Research Reports on Trending Tickers: Endo International and Immunomedics ACCESSWIRE
Nov-09-17 05:21PM  Immunomedics reports 1Q loss Associated Press
04:10PM  Immunomedics Announces First Quarter Fiscal 2018 Results and Provides Corporate Update GlobeNewswire
04:05PM  Immunomedics Appoints Michael Pehl President and Chief Executive Officer to Lead Next Phase of Transformative Growth GlobeNewswire
01:00PM  Immunomedics, Inc. to Host Earnings Call ACCESSWIRE
Nov-02-17 08:00AM  Immunomedics to Report First Quarter Fiscal 2018 Results and Host Conference Call and Webcast on November 9, 2017 GlobeNewswire +6.82%
Oct-31-17 12:13PM  Immunomedics, Inc. Value Analysis (NASDAQ:IMMU) : October 31, 2017 Capital Cube -5.13%
11:42AM  ETFs with exposure to Immunomedics, Inc. : October 31, 2017 Capital Cube
Oct-30-17 08:11AM  Immunomedics, Inc. breached its 50 day moving average in a Bullish Manner : IMMU-US : October 30, 2017 Capital Cube
Oct-27-17 09:35AM  Versartis Drops on Q3 Numbers, Hires Adviser -- Biotech Movers TheStreet.com +6.18%
Oct-23-17 08:37AM  Are Options Traders Betting on a Big Move in Immunomedics (IMMU) Stock? Zacks
Oct-05-17 12:21PM  Edited Transcript of IMMU earnings conference call or presentation 16-Aug-17 9:00pm GMT Thomson Reuters StreetEvents -8.50%
Oct-03-17 11:19AM  ETFs with exposure to Immunomedics, Inc. : October 3, 2017 Capital Cube
Sep-15-17 04:30PM  Why Carnival, Immunomedics, and Fitbit Slumped Today Motley Fool
08:00AM  Immunomedics Announces Agreements to Exchange Approximately $80.0 Million of Its 4.75% Convertible Senior Notes Due 2020 for Common Stock GlobeNewswire
Sep-11-17 09:00AM  Are Options Traders Betting on a Big Move in Immunomedics (IMMU) Stock? Zacks +5.17%
07:00AM  Immunomedics Presents Interim Phase 2 Results With Sacituzumab Govitecan (IMMU-132) in Patients With Pretreated Metastatic Urothelial Cancer GlobeNewswire
Aug-30-17 08:00AM  Immunomedics to Participate in Upcoming Investor Conferences GlobeNewswire
Aug-28-17 05:33PM  ETFs with exposure to Immunomedics, Inc. : August 28, 2017 Capital Cube +14.07%
03:30PM  Here's Why Immunomedics Rose as Much as 14.2% Today Motley Fool
Aug-24-17 12:51PM  Harry Boxer: These three biotech stocks are breaking out MarketWatch +9.88%
10:45AM  Immunomedics, Inc. :IMMU-US: Earnings Analysis: Q4, 2017 By the Numbers : August 24, 2017 Capital Cube
Aug-23-17 08:48AM  Immunomedics (IMMU) Catches Eye: Stock Up 5.1% Zacks
08:41AM  Zacks.com featured highlights: Glu Mobile, Calumet Specialty Products Partners, The Bancorp, Immunomedics and Hudbay Minerals Zacks
Aug-22-17 10:44AM  Immunomedics' Progress in Phase II Cancer Study Encouraging Zacks +5.11%
08:23AM  Immunomedics, Inc. breached its 50 day moving average in a Bullish Manner : IMMU-US : August 22, 2017 Capital Cube
Aug-21-17 02:02PM  Immunomedics, Inc. :IMMU-US: Earnings Analysis: 2017 By the Numbers : August 21, 2017 Capital Cube +7.01%
08:00AM  Immunomedics Announces Publication of Phase 2 Results With Labetuzumab Govitecan (IMMU-130) That Demonstrate Promising Efficacy as a Single Agent in Patients With Metastatic Colorectal Cancer GlobeNewswire
Aug-17-17 08:50AM  Are Options Traders Betting on a Big Move in Immunomedics (IMMU) Stock? Zacks
Aug-16-17 09:21PM  Immunomedics, Inc. Value Analysis (NASDAQ:IMMU) : August 17, 2017 Capital Cube
09:14PM  Immunomedics reports 4Q loss Associated Press
04:00PM  Immunomedics Announces Fiscal 2017 Results and Strategic Developments; Reiterates Guidance on BLA Submission Timeline GlobeNewswire
Aug-07-17 04:00PM  Immunomedics Announces Conference Call and Webcast for Fourth Quarter and Fiscal Year 2017 Results GlobeNewswire
Aug-03-17 09:46AM  Immunomedics, Inc. breached its 50 day moving average in a Bearish Manner : IMMU-US : August 3, 2017 Capital Cube
Jul-10-17 02:40PM  ETFs with exposure to Immunomedics, Inc. : July 10, 2017 Capital Cube
09:00AM  Published Results from Clinical Trials Demonstrate Therapeutic Potential for Immunomedics Sacituzumab Govitecan (IMMU-132) in the Treatment of Metastatic Solid Cancers GlobeNewswire
Jun-29-17 03:11PM  Immunomedics Announces Results of Special Stockholder Meeting GlobeNewswire
08:35AM  Options Traders Expect Huge Moves in Immunomedics (IMMU) Stock Zacks
Jun-27-17 03:20PM  ETFs with exposure to Immunomedics, Inc. : June 27, 2017 Capital Cube
Jun-16-17 03:54PM  ETFs with exposure to Immunomedics, Inc. : June 16, 2017 Capital Cube
Jun-07-17 11:05AM  Three Junior Biotechs Ready to Run Investopedia
Jun-05-17 02:22PM  ETFs with exposure to Immunomedics, Inc. : June 5, 2017 Capital Cube
Jun-01-17 08:00AM  Immunomedics to Present at Jefferies 2017 Global Healthcare Conference GlobeNewswire
May-26-17 09:33AM  Biotech Movers: Immunomedics, Aerie, Exelixis TheStreet.com
May-25-17 12:41PM  ETFs with exposure to Immunomedics, Inc. : May 25, 2017 Capital Cube
May-24-17 09:51AM  Immunomedics, Inc. :IMMU-US: Earnings Analysis: Q3, 2017 By the Numbers : May 24, 2017 Capital Cube
May-18-17 05:00AM  Edited Transcript of IMMU earnings conference call or presentation 10-May-17 9:00pm GMT Thomson Reuters StreetEvents
May-11-17 09:21PM  Edited Transcript of IMMU earnings conference call or presentation 10-May-17 9:00pm GMT Thomson Reuters StreetEvents +6.14%
May-10-17 04:10PM  Immunomedics reports 3Q loss Associated Press
04:00PM  Immunomedics Announces Third Quarter Fiscal 2017 Results and Clinical Program Developments GlobeNewswire
08:15AM  Immunomedics Announces Conference Call and Webcast for Third Quarter Fiscal 2017 Results GlobeNewswire
May-08-17 05:53PM  The Head-Scratching Reason Immunomedics Rose by as Much as 12% Motley Fool +8.02%
08:25AM  Immunomedics, Inc. breached its 50 day moving average in a Bullish Manner : IMMU-US : May 8, 2017 Capital Cube
08:00AM  Today's Research Report on Biotech Stocks to Watch: Immunomedics and Esperion Therapeutics Accesswire
06:00AM  Immunomedics Breaks Out, But Will It Last? Investopedia
May-06-17 09:10AM  Did Immunomedics Rise Too Much as Seattle Genetics Deal Terminated? 24/7 Wall St.
May-05-17 04:32PM  Immunomedics, Seattle Genetics Scrap License Deal TheStreet.com +17.56%
04:22PM  Why Immunomedics, MercadoLibre, and Pearson Jumped Today Motley Fool
01:57PM  Why Immunomedics, Inc. Rocketed Today Motley Fool
10:42AM  Biotech Movers: Immunomedics Shares Jump After License Pact with Seattle Genetics Is Terminated TheStreet.com
08:46AM  Immunomedics Delivers Business Updates, Announces Private Placement Offering and Outlines Strategic Steps to Drive Stockholder Value Business Wire
Apr-25-17 04:18PM  Immunomedics, Inc. Value Analysis (NASDAQ:IMMU) : April 25, 2017 Capital Cube +6.98%
Apr-24-17 08:41AM  Immunomedics, Inc. breached its 50 day moving average in a Bearish Manner : IMMU-US : April 24, 2017 Capital Cube
Immunomedics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune disorders, and other diseases. The company engages in developing antibody-drug conjugate (ADC) products comprising IMMU-132, an ADC that contains SN-38, which is in Phase II trials used for the treatment of patients with metastatic triple-negative breast cancer, and small-cell and non-small-cell lung cancers; IMMU-130, an anti-CEACAN5-SN-38 ADC that is in Phase II trials for the treatment of solid tumors and metastatic colorectal cancer; and IMMU-140 that targets HLA-DR for the potential treatment of liquid cancers. It also develops products for the treatment of cancer and autoimmune diseases, including epratuzumab, anti-CD22 antibody; veltuzumab, anti-CD20 antibody; milatuzumab, anti-CD74 antibody; and IMMU-114, a humanized anti-HLA-DR antibody. The company also provides LeukoScan, a diagnostic imaging product to determine the location and extent of infection/inflammation in bone. In addition, it offers other product candidates for the treatment of solid tumors and hematologic malignancies, as well as other diseases, which are in various stages of clinical and pre-clinical development. The company has a research collaboration with The Bayer Group to study epratuzumab as a thorium-227-labeled antibody; and a collaboration agreement with University of Wisconsin Carbone Cancer Center to expand IMMU-132 into prostate cancer. Immunomedics, Inc. was founded in 1982 and is headquartered in Morris Plains, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MARKISON BRIAN ADirectorNov 20Option Exercise3.1615,00047,40099,178Nov 21 05:00 PM
MARKISON BRIAN ADirectorNov 20Sale11.898,39099,72490,788Nov 21 05:00 PM
venBio Select Advisor LLCDirectorNov 15Buy10.97175,0001,919,75016,064,461Nov 16 11:47 AM
Aghazadeh BehzadDirectorNov 15Buy10.97175,0001,919,75016,064,461Nov 15 05:48 PM
venBio Select Advisor LLCDirectorNov 14Buy10.391,150,00011,948,50015,889,461Nov 16 11:47 AM
Aghazadeh BehzadDirectorNov 14Buy10.391,150,00011,948,50015,889,461Nov 15 05:48 PM
GOLDENBERG CYNTHIA LDirectorSep 01Sale12.9010,000129,000778,219Sep 05 07:10 PM
GOLDENBERG DAVID MSee RemarksSep 01Sale12.9010,000129,0003,395,578Sep 05 07:10 PM
GOLDENBERG CYNTHIA LDirectorAug 31Sale12.3810,000123,750788,219Sep 05 07:10 PM
GOLDENBERG DAVID MSee RemarksAug 31Sale12.3810,000123,7503,405,578Sep 05 07:10 PM
GOLDENBERG CYNTHIA LDirectorAug 28Sale11.5215,000172,841798,219Aug 28 08:54 PM
GOLDENBERG DAVID MSee RemarksAug 28Sale11.5610,000115,5913,415,578Aug 28 08:54 PM
GOLDENBERG CYNTHIA LDirectorAug 24Sale10.2425,000256,105813,219Aug 28 08:54 PM
GOLDENBERG CYNTHIA LDirectorAug 23Sale9.5010,00095,000838,219Aug 23 09:00 PM
GOLDENBERG DAVID MSee RemarksAug 23Sale9.5010,00095,0003,455,578Aug 23 09:00 PM
GOLDENBERG CYNTHIA LDirectorAug 22Sale9.5010,00095,000848,219Aug 23 09:00 PM
GOLDENBERG DAVID MSee RemarksAug 22Sale9.5010,00095,0003,465,578Aug 23 09:00 PM
GOLDENBERG CYNTHIA LDirectorAug 21Sale8.9720,000179,426858,219Aug 23 09:00 PM
GOLDENBERG DAVID MSee RemarksAug 21Sale8.9720,000179,4263,475,578Aug 23 09:00 PM
HCI HCI Group, Inc. daily Stock Chart
HCI [NYSE]
HCI Group, Inc.
Index- P/E- EPS (ttm)-1.65 Insider Own15.00% Shs Outstand9.68M Perf Week0.42%
Market Cap343.35M Forward P/E9.10 EPS next Y3.90 Insider Trans1.01% Shs Float7.69M Perf Month0.91%
Income-13.50M PEG- EPS next Q0.81 Inst Own75.60% Short Float12.45% Perf Quarter16.95%
Sales257.10M P/S1.34 EPS this Y-50.50% Inst Trans-9.72% Short Ratio6.28 Perf Half Y-11.83%
Book/sh22.66 P/B1.57 EPS next Y363.50% ROA-0.90% Target Price43.25 Perf Year-25.50%
Cash/sh30.21 P/C1.17 EPS next 5Y25.00% ROE-3.10% 52W Range27.11 - 50.93 Perf YTD18.63%
Dividend1.40 P/FCF5.82 EPS past 5Y16.90% ROI10.50% 52W High-30.36% Beta2.16
Dividend %3.95% Quick Ratio- Sales past 5Y23.20% Gross Margin- 52W Low30.84% ATR1.08
Employees331 Current Ratio- Sales Q/Q-31.80% Oper. Margin1.00% RSI (14)57.04 Volatility3.06% 3.03%
OptionableYes Debt/Eq1.22 EPS Q/Q-503.00% Profit Margin-2.70% Rel Volume0.28 Prev Close35.73
ShortableYes LT Debt/Eq1.22 EarningsMar 06 AMC Payout- Avg Volume152.32K Price35.47
Recom2.20 SMA201.01% SMA507.20% SMA200-7.52% Volume42,404 Change-0.73%
Sep-11-17Upgrade Sidoti Neutral → Buy
Apr-07-17Initiated SunTrust Buy $52
Dec-28-15Initiated Piper Jaffray Overweight
Oct-20-15Upgrade JMP Securities Mkt Perform → Mkt Outperform $47
Mar-17-15Downgrade Gilford Securities Buy → Neutral $50
Oct-03-14Upgrade Gilford Securities Neutral → Buy $46.50 → $52
Oct-24-13Downgrade Gilford Securities Buy → Neutral $44.50 → $45.60
Aug-30-13Upgrade Gilford Securities Neutral → Buy $37.50 → $44.50
Aug-02-13Reiterated Gilford Securities Neutral $36 → $37.50
May-28-13Downgrade Taglich Brothers Buy → Speculative Buy $22 → $38
May-08-13Downgrade Gilford Securities Buy → Neutral
Apr-01-13Reiterated Taglich Brothers Buy $27.35 → $31.95
Mar-06-13Reiterated Gilford Securities Buy $26 → $30
Feb-12-18 08:00AM  HCI Group Sets Fourth Quarter and Full Year 2017 Earnings Call for Tuesday, March 6, 2018 at 4:45 p.m. ET GlobeNewswire
Jan-24-18 08:30AM  Market Trends Toward New Normal in HCI Group, Mitek, Duluth, Gentherm, Masonite International, and AmeriGas Partners Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Jan-22-18 08:00AM  HCI Group Declares Q1 2018 Regular Quarterly Cash Dividend GlobeNewswire
Jan-16-18 08:00AM  HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in California GlobeNewswire
Dec-28-17 08:20AM  Year in Review: First Coast's tech successes in 2017 American City Business Journals
Dec-15-17 01:29PM  ETFs with exposure to HCI Group, Inc. : December 15, 2017 Capital Cube
Dec-12-17 08:00AM  HCI Group Appoints Karin Coleman to Executive Vice President GlobeNewswire
Dec-06-17 08:00AM  HCI Group Board Authorizes $20 Million Stock Repurchase Program for 2018 GlobeNewswire
Dec-05-17 12:56PM  ETFs with exposure to HCI Group, Inc. : December 5, 2017 Capital Cube
Dec-01-17 08:45AM  HCI Group, Inc. :HCI-US: Earnings Analysis: Q3, 2017 By the Numbers : December 1, 2017 Capital Cube
Nov-30-17 08:00AM  HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in Ohio GlobeNewswire
Nov-17-17 10:17AM  HCI Group, Inc. : HCI-US: Dividend Analysis : November 17th, 2017 (record date) : By the numbers : November 17, 2017 Capital Cube
Nov-07-17 07:34PM  Edited Transcript of HCI earnings conference call or presentation 2-Nov-17 8:45pm GMT Thomson Reuters StreetEvents
Nov-06-17 11:45AM  ETFs with exposure to HCI Group, Inc. : November 6, 2017 Capital Cube
05:38AM  HCI Group reports 3Q loss Associated Press
Nov-02-17 04:15PM  HCI Group Reports Third Quarter and Nine-Month 2017 Results GlobeNewswire
12:20PM  HCI Group, Inc. to Host Earnings Call ACCESSWIRE
Nov-01-17 08:27AM  HCI Group, Inc. breached its 50 day moving average in a Bearish Manner : HCI-US : November 1, 2017 Capital Cube
Oct-27-17 08:00AM  HCI Group Real Estate Division Acquires New Office Building GlobeNewswire
Oct-24-17 08:00AM  HCI Group Declares Q4 2017 Regular Quarterly Cash Dividend GlobeNewswire
Oct-20-17 09:17AM  New Strong Sell Stocks for October 20th Zacks
Oct-17-17 10:13AM  HCI Group, Inc. Value Analysis (NYSE:HCI) : October 17, 2017 Capital Cube
Oct-16-17 08:09AM  HCI Group, Inc. breached its 50 day moving average in a Bullish Manner : HCI-US : October 16, 2017 Capital Cube
Oct-09-17 08:00AM  HCI Group Sets Third Quarter 2017 Earnings Call for Thursday, November 2, 2017 at 4:45 p.m. ET GlobeNewswire
Oct-06-17 05:06PM  State Auto Financial (STFC) Projects Q3 Cat Loss Estimates Zacks
08:00AM  HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in North Carolina GlobeNewswire
Sep-27-17 09:29AM  United Insurance (UIHC) Keeps a Count of Q3 Catastrophe Loss Zacks
Sep-25-17 04:00PM  Allstate Estimates Catastrophe Loss from Hurricane Harvey Zacks
Sep-21-17 08:00AM  HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in New Jersey GlobeNewswire
Sep-19-17 10:33AM  HCI Group (HCI) Calculates Possible Irma Catastrophe Loss Zacks
08:00AM  HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in Texas GlobeNewswire
Sep-18-17 05:56PM  ETFs with exposure to HCI Group, Inc. : September 18, 2017 Capital Cube
08:00AM  HCI Group Insurance Subsidiaries Issue Loss Estimates from Hurricane Irma GlobeNewswire
Sep-15-17 03:16PM  HCI Group, Inc. : HCI-US: Dividend Analysis : August 18th, 2017 (record date) : By the numbers : September 15, 2017 Capital Cube
11:51AM  HCI Group, Inc. :HCI-US: Earnings Analysis: Q2, 2017 By the Numbers : September 15, 2017 Capital Cube
Sep-12-17 05:00PM  Universal Insurance and other big Florida insurers see a quick rebound in stock prices American City Business Journals
Sep-11-17 08:05AM  How Tampa Bay and Florida insurers are making it through the storm American City Business Journals +17.48%
Sep-08-17 01:40PM  Hurricane Irma causes Florida insurance stocks to plunge American City Business Journals
10:22AM  The Zacks Analyst Blog Highlights: HCI Group, Lumber Liquidators, Tempur Sealy International and Home Depot Zacks
Sep-07-17 04:30PM  Hurricane Irma: These Insurance Stocks Have the Most Exposure to Florida Zacks -8.46%
08:48AM  HCI Group (HCI) in Focus: Stock Moves 5.8% Higher Zacks
Sep-06-17 11:08AM  ETFs to Watch in Harvey Aftermath & New Hurricane Irma Zacks +5.79%
Sep-05-17 03:25PM  Irma batters Tampa Bay insurance stocks American City Business Journals -20.01%
Aug-25-17 08:15AM  HCI Group to Participate at the 6th Annual Liolios Gateway Conference and the 2017 KBW Insurance Conference in September 2017 GlobeNewswire
08:00AM  HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in South Carolina GlobeNewswire
Aug-23-17 08:34AM  Liolios Releases Presenting Company Roster for its 6th Annual Gateway Conference on September 6-7 in San Francisco GlobeNewswire
Aug-17-17 08:00AM  HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in Maryland GlobeNewswire
Aug-12-17 01:50AM  Edited Transcript of HCI earnings conference call or presentation 2-Aug-17 8:45pm GMT Thomson Reuters StreetEvents
Aug-04-17 03:22AM  HCI Group posts 2Q profit Associated Press
Aug-02-17 04:15PM  HCI Group Reports Second Quarter and Six-Month 2017 Results GlobeNewswire
Aug-01-17 04:10PM  Investor Network Invites You to the HCI Group Second Quarter 2017 Earnings Conference Call and Webcast Live on Wednesday, August 2, 2017 ACCESSWIRE
Jul-31-17 06:25PM  HCI Group, Inc. Value Analysis (NYSE:HCI) : July 31, 2017 Capital Cube
Jul-17-17 09:48AM  HCI Group, Inc. breached its 50 day moving average in a Bearish Manner : HCI-US : July 17, 2017 Capital Cube
Jul-14-17 08:05AM  HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in Pennsylvania GlobeNewswire
08:00AM  HCI Group Subsidiary Homeowners Choice Approved to Write Flood Insurance in Arkansas GlobeNewswire
Jul-10-17 08:00AM  HCI Group Declares Q3 2017 Regular Quarterly Cash Dividend GlobeNewswire
Jun-22-17 08:00AM  HCI Group Insurance Subsidiaries Expand Flood Insurance into Nine Additional States GlobeNewswire
Jun-13-17 04:15PM  HCI Group to Participate at the JMP Financial Services and Real Estate Conference on Thursday, June 22, 2017 GlobeNewswire
Jun-12-17 02:07PM  ETFs with exposure to HCI Group, Inc. : June 12, 2017 Capital Cube
Jun-09-17 09:46AM  HCI Group, Inc. :HCI-US: Earnings Analysis: Q1, 2017 By the Numbers : June 9, 2017 Capital Cube
08:10AM  HCI Group, Inc. breached its 50 day moving average in a Bullish Manner : HCI-US : June 9, 2017 Capital Cube
Jun-01-17 08:30AM  HCI Group Insurance Subsidiary, Homeowners Choice, Improves Coverage and Reduces Risk GlobeNewswire
May-19-17 12:11PM  HCI Group, Inc. : HCI-US: Dividend Analysis : May 19th, 2017 (record date) : By the numbers : May 19, 2017 Capital Cube
May-10-17 07:05PM  Edited Transcript of HCI earnings conference call or presentation 4-May-17 8:45pm GMT Thomson Reuters StreetEvents
May-05-17 05:03AM  HCI Group posts 1Q profit Associated Press
May-04-17 04:15PM  HCI Group Reports First Quarter 2017 Results GlobeNewswire
May-03-17 04:10PM  Investor Network Invites You to the HCI Group First Quarter 2017 Earnings Conference Call and Webcast Live on Thursday, May 4, 2017 Accesswire
Apr-26-17 08:22AM  HCI Group, Inc. breached its 50 day moving average in a Bullish Manner : HCI-US : April 26, 2017 Capital Cube
Apr-24-17 03:10PM  Heres what happened when HCI Groups biggest shareholder bought more stock American City Business Journals
08:00AM  HCI Group Terminates Shareholder Rights Plan GlobeNewswire
Apr-19-17 08:00AM  HCI Group Declares Q2 2017 Regular Quarterly Cash Dividend GlobeNewswire
Apr-17-17 08:00AM  HCI Group Sets First Quarter 2017 Earnings Call for Thursday, May 4, 2017 at 4:45 p.m. ET GlobeNewswire
Apr-12-17 08:05AM  HCI Group, Inc. breached its 50 day moving average in a Bullish Manner : HCI-US : April 12, 2017 Capital Cube
Apr-05-17 04:05PM  HCI Group Completes Redemption of 8% Series A Senior Notes Due 2020 GlobeNewswire
Mar-31-17 08:09AM  HCI Group, Inc. breached its 50 day moving average in a Bullish Manner : HCI-US : March 31, 2017 Capital Cube
Mar-27-17 10:59AM  HCI Group, Inc. : HCI-US: Dividend Analysis : February 17th, 2017 (record date) : By the numbers : March 27, 2017 Capital Cube
Mar-14-17 04:01PM  HCI Group to Redeem 8% Senior Notes Due 2020 GlobeNewswire
Mar-13-17 08:00AM  HCI Group Sets Annual Shareholders' Meeting and Record Date GlobeNewswire
Mar-03-17 04:21PM  HCI GROUP, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obliga
Mar-01-17 09:24AM  Torchmark (TMK) Rewards Shareholders with 7% Dividend Hike
Feb-28-17 07:04PM  HCI GROUP, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements an
01:04PM  HCI GROUP, INC. Financials
09:15AM  HCI Group Announces Pricing of $125 Million Offering of Convertible Senior Notes Due 2037 GlobeNewswire
06:00AM  HCI Group Announces Proposed $115 Million Offering of Convertible Senior Notes Due 2037 GlobeNewswire
Feb-24-17 08:00AM  UMs Florida stock index bests S&P 500 at bizjournals.com
08:00AM  UMs Florida stock index bests S&P 500 American City Business Journals
Feb-23-17 04:59PM  HCI Group, Inc.: Strong price momentum but will it sustain? Capital Cube
12:53PM  HCI Group, Inc. :HCI-US: Earnings Analysis: 2016 By the Numbers : February 23, 2017 Capital Cube
10:50AM  HCI Group, Inc. :HCI-US: Earnings Analysis: Q4, 2016 By the Numbers : February 23, 2017
Feb-22-17 05:06PM  HCI GROUP, INC. Files SEC form 10-K, Annual Report +10.44%
Feb-21-17 10:18PM  Edited Transcript of HCI earnings conference call or presentation 21-Feb-17 9:45pm GMT
05:22PM  HCI Group posts 4Q profit
04:44PM  HCI GROUP, INC. Files SEC form 8-K, Results of Operations and Financial Condition
04:15PM  HCI Group Reports Fourth Quarter and Full Year 2016 Results GlobeNewswire
07:07AM  Q4 2016 HCI Group Inc Earnings Release - After Market Close
Feb-20-17 04:05PM  Investor Network Invites You to the HCI Group Fourth Quarter 2016 Earnings Conference Call and Webcast Live on Tuesday, February 21, 2017 Accesswire
09:08AM  XL Group Increases Dividend Payout, Okays Share Buyback
Feb-16-17 08:00AM  HCI Group to Participate at the 42nd Annual AIFA Conference on Tuesday, March 7, 2017 GlobeNewswire
Feb-01-17 08:00AM  HCI Group Real Estate Division Acquires 100% Ownership of Newly-Built Melbourne, Florida Shopping Center GlobeNewswire
Jan-31-17 08:00AM  HCI Group Sets Fourth Quarter and Full Year 2016 Earnings Call for Tuesday, February 21, 2017 at 4:45 p.m. ET GlobeNewswire
HCI Group, Inc. engages in the property and casualty insurance business in Florida. It provides property and casualty insurance to homeowners, condominium owners, and tenants; and reinsurance. The company also leases office properties and retail shopping centers; and owns and operates one full-service restaurant and two marinas. In addition, it offers designs and develops Web-based applications and products for mobile devices. The company was formerly known as Homeowners Choice, Inc. and changed its name to HCI Group, Inc. in May 2013. HCI Group, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Politis GregoryDirectorDec 19Buy29.102,00058,200196,000Dec 21 04:03 PM
Politis GregoryDirectorDec 18Buy29.972,00059,946194,000Dec 19 03:51 PM
Politis GregoryDirectorDec 15Buy29.282,00058,552192,000Dec 19 03:51 PM
Patel PareshChief Executive OfficerDec 08Buy30.301,00030,30035,000Dec 12 03:50 PM
Macchiarola James JDirectorNov 27Buy30.446,000182,6236,000Nov 29 03:55 PM
Harmsworth James MarkChief Financial OfficerSep 21Buy36.9350018,467500Sep 21 04:33 PM
Graham Andrew L.GC/Corporate SecretarySep 21Buy36.45652,3692,825Sep 21 04:31 PM
Patel PareshChief Executive OfficerSep 20Buy36.061,00036,062285,000Sep 21 04:29 PM
Patel PareshChief Executive OfficerJun 16Option Exercise2.5030,00075,000227,000Jun 20 03:48 PM
HSKA Heska Corporation daily Stock Chart
HSKA [NASD]
Heska Corporation
Index- P/E31.51 EPS (ttm)1.90 Insider Own2.40% Shs Outstand7.17M Perf Week-0.25%
Market Cap429.91M Forward P/E28.48 EPS next Y2.11 Insider Trans-9.35% Shs Float6.57M Perf Month-27.08%
Income14.50M PEG1.70 EPS next Q0.58 Inst Own89.80% Short Float5.93% Perf Quarter-30.23%
Sales135.70M P/S3.17 EPS this Y92.80% Inst Trans8.68% Short Ratio4.36 Perf Half Y-39.79%
Book/sh14.15 P/B4.24 EPS next Y4.00% ROA11.00% Target Price98.83 Perf Year-27.07%
Cash/sh1.03 P/C58.10 EPS next 5Y18.50% ROE15.30% 52W Range56.59 - 115.00 Perf YTD-25.25%
Dividend- P/FCF61.42 EPS past 5Y28.90% ROI13.90% 52W High-47.86% Beta0.89
Dividend %- Quick Ratio1.10 Sales past 5Y13.20% Gross Margin42.60% 52W Low5.96% ATR3.10
Employees327 Current Ratio2.30 Sales Q/Q-6.00% Oper. Margin12.90% RSI (14)28.30 Volatility4.45% 5.02%
OptionableNo Debt/Eq0.06 EPS Q/Q-10.50% Profit Margin10.70% Rel Volume0.67 Prev Close61.00
ShortableYes LT Debt/Eq0.00 EarningsFeb 28 BMO Payout0.00% Avg Volume89.29K Price59.96
Recom2.10 SMA20-13.16% SMA50-20.53% SMA200-33.70% Volume59,755 Change-1.70%
Feb-05-18Upgrade Sidoti Neutral → Buy $94
Nov-03-17Reiterated B. Riley FBR, Inc. Neutral $96.50 → $93
Aug-03-17Reiterated The Benchmark Company Buy $106 → $120
Mar-01-17Reiterated The Benchmark Company Buy $100 → $106
Jan-26-17Downgrade CL King Buy → Neutral
Nov-29-16Initiated The Benchmark Company Buy $78
Aug-04-16Downgrade Gabelli & Co Buy → Hold
Jul-01-16Initiated Sidoti Buy
Apr-01-16Initiated CL King Buy
Dec-12-14Initiated Gabelli & Co Buy $20
Aug-08-13Reiterated Feltl & Co. Strong Buy $12.50 → $9.50
Sep-11-12Initiated Feltl & Co. Strong Buy $13.50
Aug-13-12Downgrade C.K. Cooper Buy → Hold
Jun-08-12Initiated C.K. Cooper Buy $20
Feb-09-18 08:00AM  Heska Schedules Fourth Quarter and Year End 2017 Financial Results Conference Call for February 28, 2018 PR Newswire
Jan-30-18 07:30AM  Consolidated Research: 2018 Summary Expectations for Immune Design, Primoris Services, Scotts Miracle-Gro, Heska, Calyxt, and Urstadt Biddle Properties Fundamental Analysis, Key Performance Indications GlobeNewswire
Dec-01-17 04:05PM  Heska promotes Catherine Grassman to Vice President and Chief Accounting Officer and announces executive departure PR Newswire
Nov-27-17 02:09PM  ETFs with exposure to Heska Corp. : November 27, 2017 Capital Cube
Nov-21-17 12:33PM  Mariko Gordon Starts 5 New Positions in 3rd Quarter GuruFocus.com
Nov-06-17 06:16PM  Edited Transcript of HSKA earnings conference call or presentation 2-Nov-17 3:00pm GMT Thomson Reuters StreetEvents
01:07PM  Heska Corp. Value Analysis (NASDAQ:HSKA) : November 6, 2017 Capital Cube
Nov-03-17 08:34AM  Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : November 3, 2017 Capital Cube +6.09%
Nov-02-17 08:25AM  Heska beats 3Q profit forecasts Associated Press -15.74%
08:00AM  Heska Reports Third Quarter Results PR Newswire
Nov-01-17 08:00AM  Heska Announces 7-Year Agreement with PetVetCare Centers PR Newswire
Oct-31-17 08:00AM  Heska extends product line with new Element COAG Veterinary Analyzer PR Newswire
Oct-30-17 11:57AM  ETFs with exposure to Heska Corp. : October 30, 2017 Capital Cube
Oct-12-17 08:00AM  Heska Schedules Third Quarter 2017 Financial Results Conference Call for November 2, 2017 PR Newswire
Oct-09-17 11:38AM  ETFs with exposure to Heska Corp. : October 9, 2017 Capital Cube
08:41AM  Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : October 9, 2017 Capital Cube
Oct-06-17 09:04AM  Heska Corp. :HSKA-US: Earnings Analysis: Q2, 2017 By the Numbers : October 6, 2017 Capital Cube
Sep-18-17 10:01AM  TESARO Ovarian Cancer Drug Zejula Gets Positive CHMP Opinion Zacks
Sep-15-17 11:22AM  The Zacks Analyst Blog Highlights: KEMET, Heska, Spirit AeroSystems, American Woodmark and Kraton Zacks
Sep-14-17 05:39PM  4 Biotech Stocks That Show Promise on Sustainable Growth Zacks
09:33AM  Obama-Trump Bull Run is the Second Best Ever: Top 5 Gainers Zacks
Aug-28-17 11:01AM  Zacks.com featured highlights Sanderson Farm, Heska Corp, Vanda Pharmaceuticals Lantheus and NVR Zacks
Aug-25-17 10:43AM  5 Efficient Stocks to Buy for a Healthy Portfolio Zacks
Aug-24-17 08:26AM  Heska Corp. breached its 50 day moving average in a Bullish Manner : HSKA-US : August 24, 2017 Capital Cube
Aug-23-17 04:11PM  Edited Transcript of HSKA earnings conference call or presentation 31-Jul-17 3:00pm GMT Thomson Reuters StreetEvents
08:00AM  Heska to Present at CL King's 15th Annual Best Ideas Conference 2017 on September 14, 2017 PR Newswire
Aug-16-17 09:16PM  Heska Corp. Value Analysis (NASDAQ:HSKA) : August 17, 2017 Capital Cube
Aug-04-17 09:50AM  Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : August 4, 2017 Capital Cube
Jul-31-17 11:02PM  Heska posts 2Q profit Associated Press
08:00AM  Heska Reports Second Quarter Results PR Newswire
06:45AM  Investor Network: HESKA CORP to Host Earnings Call ACCESSWIRE
Jul-27-17 07:34PM  Heska Adds Growth Capital with $30 Million Credit Agreement with JPMorgan Chase PR Newswire
Jul-20-17 04:05PM  Heska to Present at Canaccord Genuity 37th Annual Growth Conference on August 10 PR Newswire
Jul-11-17 02:38PM  ETFs with exposure to Heska Corp. : July 11, 2017 Capital Cube
08:00AM  Heska Schedules Second Quarter 2017 Financial Results Conference Call for July 31, 2017 PR Newswire
Jun-30-17 03:02PM  ETFs with exposure to Heska Corp. : June 30, 2017 Capital Cube
Jun-22-17 08:09AM  Heska Corp. breached its 50 day moving average in a Bullish Manner : HSKA-US : June 22, 2017 Capital Cube
Jun-19-17 03:29PM  ETFs with exposure to Heska Corp. : June 19, 2017 Capital Cube
Jun-16-17 11:50AM  Heska Corp. :HSKA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017 Capital Cube
Jun-13-17 09:00AM  Scott Humphrey Joins Heska's Board of Directors PR Newswire
Jun-08-17 02:05PM  Edited Transcript of HSKA earnings conference call or presentation 2-May-17 3:00pm GMT Thomson Reuters StreetEvents
Jun-02-17 08:46AM  Why Heska (HSKA) Could Be Positioned for a Surge Zacks
May-26-17 08:27AM  Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : May 26, 2017 Capital Cube
May-04-17 04:51PM  Heska Corp. Value Analysis (NASDAQ:HSKA) : May 4, 2017 Capital Cube
08:00AM  Edited Transcript of HSKA earnings conference call or presentation 2-May-17 3:00pm GMT Thomson Reuters StreetEvents
May-03-17 08:46AM  Heska Corp. breached its 50 day moving average in a Bearish Manner : HSKA-US : May 3, 2017 Capital Cube -5.00%
May-02-17 12:33PM  Here's Why Heska Corporation Is Dropping Today Motley Fool -14.21%
08:15AM  Heska posts 1Q profit Associated Press
08:05AM  Investor Network: Heska Corporation to Host Earnings Call Accesswire
08:00AM  Heska Reports First Quarter Results PR Newswire
May-01-17 09:59AM  Hill-Rom (HRC) Beats Earnings & Revenue Estimates in Q2 Zacks
Apr-28-17 10:43AM  Sarepta (SRPT) Q1 Loss Narrows, Exondys 51 Sales Pick Up Zacks
09:57AM  Seattle Genetics (SGEN) Q1 Loss Widens, Sales Top Estimates Zacks
09:31AM  Align Technology (ALGN) Beats on Q1 Earnings and Revenues Zacks
Apr-27-17 09:03AM  Chemed's (CHE) Earnings and Revenues Beat Estimates in Q1 Zacks
08:00AM  Heska To Present at Four Upcoming Conferences PR Newswire
Apr-26-17 11:10AM  Medical Device Maker Bolts Higher On Earnings In Massive Volume Investor's Business Daily
Apr-25-17 05:19PM  Reminder: Heska Annual Meeting of Stockholders on May 1, 2017 PR Newswire
Apr-20-17 06:07PM  CytRx Gets Clarity from FDA for Aldoxorubicin NDA, Shares Up Zacks
09:30AM  Zacks.com featured highlights: Heska, Zeltiq Aesthetics, YY, MaxLinear and Teradyne Zacks
Apr-19-17 10:38AM  Ultragenyx's Hypophosphatemia Drug Succeeds in Phase III Zacks
07:42AM  Create an Efficient Portfolio with 5 Top Stocks Zacks
Apr-18-17 10:08AM  Bristol-Myers and Nordic Ink Biomarker Collaboration Deal Zacks
09:29AM  Rigel Pharmaceuticals Files NDA for Thrombocytopenia Drug Zacks
Apr-17-17 09:47AM  Eli Lilly's Rheumatoid Arthritis Drug Gets CRL in the U.S. Zacks
Apr-13-17 08:58AM  Illumina (ILMN) Launches VeriSeq NIPT Solution in Europe Zacks
08:00AM  Heska Schedules First Quarter 2017 Financial Results Conference Call for May 2, 2017 PR Newswire
Apr-12-17 08:00AM  Heska Schedules Annual Meeting of Stockholders for May 1, 2017 PR Newswire
Apr-10-17 05:27PM  Gilead (GILD) HCV Drugs Gets FDA Nod for Label Expansion Zacks
05:18PM  Roche's Lung Cancer Drug Alecensa Meets Primary Endpoint Zacks
Apr-06-17 09:57AM  Bristol-Myers' (BMY) sBLA For Opdivo Accepted by the FDA Zacks
Apr-05-17 08:35PM  Today's Strong Buy Stocks at New Highs Zacks
03:36PM  Celgene (CELG) Gets Paragraph IV Notice Letter for Pomalyst Zacks
12:48PM  Roche Announces Positive Data on Lung Cancer Drug Alecensa Zacks
09:10AM  Amedisys (AMED) Poised on Strong Home Health, Risks Remain Zacks
Apr-04-17 12:01PM  Bristol-Myers Announces Data on Immuno-oncology Drug Opdivo Zacks
11:12AM  QIAGEN Releases Favorable GeneReader Results, Expands in NGS Zacks
09:30AM  Zacks.com featured highlights: Heska, Quidel, Trinseo S.A., Advanced Energy Industries and Pioneer Natural Resources Zacks
Apr-03-17 09:17AM  BioDelivery to Grant New Patents for its Marketed Drugs Zacks
08:20AM  5 Stocks with Solid Efficiency Ratio to Buy in April Zacks
Mar-30-17 02:11PM  Roche's Rituxan Gets FDA Advisory Committee's Recommendation +7.30%
02:11PM  Roche's Rituxan Gets FDA Advisory Committee's Recommendation Investopedia
12:35PM  Bill Ackman Apologizes for Valeant Investment Error at Investopedia
11:30AM  Acorda Presents Data for Parkinson's Candidate CVT-301 at Investopedia
09:46AM  Amgen's Leukemia Drug Accepted for Priority Review by FDA at Investopedia
Mar-29-17 06:21PM  Gartner Set to Join S&P 500; Dun & Bradstreet, Wintrust Financial and INC Research to Join S&P MidCap 400; Heska to Join S&P SmallCap 600 PR Newswire
05:43PM  Roche's Ocrevus Wins FDA Approval for 2 Forms of Sclerosis
05:18PM  Athersys (ATHX) Stock Rallies as William Blair Initiates Coverage at Investopedia
04:51PM  Corcept (CORT) Strives to Commercialize Key Drug Korlym
10:45AM  Vertex Combo Data on Kalydeco+VX-661 Positive in Phase III
10:34AM  Orexigen Posts Wider-than-Expected Loss in Q4; Sales Up Y/Y
10:21AM  Regeneron & Sanofi's Atopic Dermatitis Drug Gets FDA Nod
Mar-28-17 06:03PM  Tesaro Wins FDA Approval for Ovarian Cancer Drug Zejula
05:51PM  Will Endo's Troubles Continue to Dent Performance in 2017?
Mar-27-17 08:39AM  Why Heska Corporation (HSKA) Could Be an Impressive Growth Stock
Mar-23-17 05:03PM  Shire (SHPG) Rare Disease Drug Gets Fast Track Designation
10:16AM  Alexion (ALXN) Files for Soliris' Label Expansion in Japan
08:15AM  XBiotech (XBIT) Catches Eye: Stock Moves Up 11.6% in Session
Mar-21-17 04:32PM  Valeant's (VRX) Glaucoma Candidate Gets PDUFA Date from FDA
04:22PM  Mylan Receives Tentative Approval from FDA for HIV Therapy
Heska Corporation develops, manufactures, and markets advanced veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Europe, and internationally. It operates through two segments, Core Companion Animal Health; and Other Vaccines, Pharmaceuticals and Products. The Core Companion Animal Health segment offers Element DC and DRI-CHEM 7000 veterinary chemistry analyzers for blood chemistry and electrolyte analysis; HT5 and HEMATRUE veterinary hematology analyzers to measure white and red blood cell count, platelet count, and hemoglobin levels in animals; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and IV pumps. This segment also provides veterinary imaging instruments and services, such as digital radiography solutions and ultrasound systems, as well as sells mobile digital radiography products; point-of-care heartworm diagnostic test products for dogs and cats; TRI-HEART Plus Chewable Tablets for the preventive treatment of canine heartworm infection, and treatment and control of ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels. The Other Vaccines, Pharmaceuticals and Products segment offers bovine vaccines; biological and pharmaceutical products for other animal health companies; and various turnkey services comprising research, licensing, production, labeling, and packaging, as well as provides validation support and distribution services. The company sells its products to veterinarians through a field organization, a telephone sales force, and independent third-party distributors, as well as trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. Heska Corporation was founded in 1988 and is headquartered in Loveland, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
NAPOLITANO JASON ACOO, Chief Strategist and Sec.Dec 28Option Exercise18.3011,000201,30043,119Dec 29 04:43 PM
Wisnewski NancyEVP, Diag. Ops & Prod. Dev.Dec 13Option Exercise18.307,000128,10045,128Dec 15 01:57 PM
McGinley Michael JPresi, Biologic. & Pharm.Nov 30Sale86.026,500559,12492,446Dec 04 02:40 PM
McGinley Michael JPresi, Biologic. & Pharm.Nov 29Sale87.027,025611,28298,946Nov 29 06:16 PM
McGinley Michael JPresi, Biologic. & Pharm.Nov 28Sale88.1980070,549105,971Nov 29 06:16 PM
McGinley Michael JPresi, Biologic. & Pharm.Nov 27Sale88.54189106,771Nov 29 06:16 PM
Wisnewski NancyEVP, Diag. Ops & Prod. Dev.Aug 31Sale102.2182584,32738,114Aug 31 05:28 PM
McMahon JohnVP, Chief Financial OfficerAug 30Option Exercise63.322,608165,1442,676Aug 31 05:26 PM
McMahon JohnVP, Chief Financial OfficerAug 30Sale101.172,608263,85768Aug 31 05:26 PM
Asakowicz SteveEVP, Comp. Animal Health SalesJun 01Option Exercise18.133826,92610,382Jun 01 05:10 PM
Asakowicz SteveEVP, Comp. Animal Health SalesJun 01Sale100.0838238,23110,000Jun 01 05:10 PM
Lippincott RodEVP, Comp. Animal Health SalesMay 31Option Exercise46.794,471209,20212,709May 31 02:04 PM
Lippincott RodEVP, Comp. Animal Health SalesMay 31Sale98.004,471438,1589,814May 31 02:04 PM
McGinley Michael JPresi, Biologic. & Pharm.May 31Sale98.5311,1891,102,434106,747Jun 01 05:08 PM
Lippincott RodEVP, Comp. Animal Health SalesMay 26Option Exercise13.326,75690,01612,628May 31 02:04 PM
Lippincott RodEVP, Comp. Animal Health SalesMay 26Sale98.006,756662,1119,814May 31 02:04 PM
Wisnewski NancyEVP, Diag. Ops & Prod. Dev.May 24Sale100.1725025,04238,901May 25 04:49 PM
NAPOLITANO JASON ACOO, Chief Strategist and Sec.May 24Sale100.505,000502,50032,119May 26 12:51 PM
WRENN CAROLDirectorMay 23Option Exercise8.101,63013,2036,174May 25 04:46 PM
McMahon JohnVP, Chief Financial OfficerMay 23Option Exercise36.3541715,159462May 25 04:48 PM
WRENN CAROLDirectorMay 23Sale96.951,630158,0244,544May 25 04:46 PM
McMahon JohnVP, Chief Financial OfficerMay 23Sale97.0058756,9400May 25 04:48 PM
Larson Sharon J.DirectorMay 04Buy90.001,00090,0003,294May 05 11:25 AM
GORDON G IRWINDirectorMay 01Option Exercise12.9219,016245,66033,073May 02 05:44 PM
NAPOLITANO JASON ACOO, Chief Strategist and Sec.Apr 11Sale100.7320020,14637,119Apr 12 01:23 PM
NAPOLITANO JASON ACOO, Chief Strategist and Sec.Apr 10Sale103.4990093,13737,319Apr 12 01:23 PM
NAPOLITANO JASON ACOO, Chief Strategist and Sec.Apr 10Sale102.943,900401,48238,219Apr 12 01:17 PM
Lippincott RodEVP, Comp. Animal Health SalesMar 09Option Exercise10.105,15752,07813,025Mar 09 02:08 PM
McMahon JohnVP, Chief Financial OfficerMar 09Option Exercise37.7570826,729658Mar 09 02:11 PM
Wisnewski NancyEVP, Diag. Ops & Prod. Dev.Mar 09Sale96.6450048,32139,151Mar 10 01:15 PM
McMahon JohnVP, Chief Financial OfficerMar 09Sale97.4270868,97375Mar 09 02:11 PM
Lippincott RodEVP, Comp. Animal Health SalesMar 09Sale97.875,157504,7219,814Mar 09 02:08 PM
Wilson Kevin S.CEO and PresidentMar 06Sale90.008,000720,0006,432Mar 06 05:13 PM
Eyl Steven M.EVP, Global Sales & MarketingMar 02Option Exercise7.3610,00073,60021,271Mar 06 05:12 PM
Eyl Steven M.EVP, Global Sales & MarketingMar 02Sale89.2610,000892,55411,271Mar 06 05:12 PM